These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 8280448)

  • 1. [Three cases of hypofibrinogenemia induced by chemotherapy with a combination of synthetic ACTH and valproic acid].
    Tokuda K; Kodani N; Ogino T
    No To Hattatsu; 1994 Jan; 26(1):50-6. PubMed ID: 8280448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood coagulation dynamics during adrenocorticotropic hormone therapy in pediatric patients with infantile spasms.
    Takeda Y; Sakakibara T; Ogiwara K; Nogami K
    Brain Dev; 2022 Sep; 44(8):546-550. PubMed ID: 35501182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper and zinc levels in epileptic children with valproate treatment.
    Kaji M; Ito M; Okuno T; Momoi T; Sasaki H; Yamanaka C; Yorifuji T; Mikawa H
    Epilepsia; 1992; 33(3):555-7. PubMed ID: 1592036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypofibrinogenemia caused by adrenocorticotropic hormone for infantile spasms: a case report.
    Kamei A; Araya N; Akasaka M; Mizuma K; Asami M; Tanifuji S; Chida S
    Brain Dev; 2015 Jan; 37(1):137-9. PubMed ID: 24735983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood ammonia level during valproic acid therapy.
    Kugoh T; Yamamoto M; Hosokawa K
    Jpn J Psychiatry Neurol; 1986 Dec; 40(4):663-8. PubMed ID: 3110472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the carnitine metabolism in epileptic children treated with valproic acid.
    Chung S; Choi J; Hyun T; Rha Y; Bae C
    J Korean Med Sci; 1997 Dec; 12(6):553-8. PubMed ID: 9443096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclinical hypothyroidism during valproic acid therapy in children and adolescents with epilepsy.
    Kim SH; Chung HR; Kim SH; Kim H; Lim BC; Chae JH; Kim KJ; Hwang YS; Hwang H
    Neuropediatrics; 2012 Jun; 43(3):135-9. PubMed ID: 22618302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
    Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
    Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy.
    Geda G; Caksen H; Içağasioğlu D
    Acta Neurol Belg; 2002 Sep; 102(3):122-6. PubMed ID: 12400250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of West syndrome: present and future perspectives].
    Seki T
    No To Hattatsu; 1997 Mar; 29(2):91-9. PubMed ID: 9071184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of fetal hemoglobin synthesis indicating differentiation induction in children receiving valproic acid.
    Kieslich M; Schwabe D; Cinatl J; Driever PH
    Pediatr Hematol Oncol; 2003; 20(1):15-22. PubMed ID: 12687749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Valproic acid-induced idiosyncratic liver injury in 4 cases].
    Xiong H; Liu CT; Zhang YH; Bao XH; Jiang YW; Zhao H; Wu XP; Qin J
    Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):890-4. PubMed ID: 23324142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproic acid-associated low fibrinogen and delayed intracranial hemorrhage: case report and mini literature review.
    Chen HF; Xu LP; Luo ZY; Yu ZQ; Li ZY; Cui QY; Qin LM; Ren YY; Shen HS; Tang JQ; Jin LJ; Zhu JJ; Wang J; Wang KY; Wu TQ; Wang ZY
    Drug Des Devel Ther; 2013; 7():767-70. PubMed ID: 23976844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of serum albumin on free fractions of phenobarbital and valproic acid in patients with convulsive seizures.
    Sadahiro N; Kodama S; Matsui T; Komatsu M; Matsuo T
    Brain Dev; 1985; 7(4):377-84. PubMed ID: 3933372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsy.
    Imaizumi T; Izumi T; Fukuyama Y
    Brain Dev; 1992 Sep; 14(5):304-8. PubMed ID: 1456384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Seizure and developmental prognosis of West syndrome--combination therapy with high-dose vitamin B6, valproate and low-dose ACTH].
    Miyajima T; Ito M; Fujii T; Okuno T
    No To Hattatsu; 2001 Nov; 33(6):498-504. PubMed ID: 11725517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential relationships between transaminase abnormality and valproic acid clearance or serum carnitine concentrations in Japanese epileptic patients.
    Goto S; Seo T; Hagiwara T; Ueda K; Yamauchi T; Nagata S; Ando Y; Ishitsu T; Nakagawa K
    J Pharm Pharmacol; 2008 Feb; 60(2):267-72. PubMed ID: 18237476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.